Clinical Trial Update: Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing Anrotenil hydrochloride capsule as first-line chemotherapy after failure in soft tissue sarcoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anrotenil hydrochloride capsule (Anrotenil hydrochloride)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Soft Tissue Sarcomas | Phase 4 | Status: COMPLETED